[2] Although Martin was named chairman of the newly chartered organization in December, 1941, activities were put on hold in the aftermath of the attack on Pearl Harbor and the beginning of US involvement in World War II.
Though he only stayed in this role for four years, Lazier is credited with recruiting many figures that shaped the history of the organization, including Howard E.
[5] In celebration of this milestone the director of National Institutes of Health (NIH), Francis Collins, produced a video congratulating the organization on its anniversary.
Previously, he worked as the director of External Affairs at the University of Alabama at Birmingham, as an assistant professor of economics at UAB and as a non-resident senior fellow at The Brookings Institution.
Their current service areas include: High Throughput Screening (HTS),[8] Chemistry, Oncology, Infectious Disease, Neuroscience, and the Center for Neuromolecular Research.
[10][11] He has been named a Fellow of the National Academy of Inventors (NAI) in recognition of his wide-ranging contributions to pharmaceutical research and drug discovery efforts.
Clofarabine, a second-generation nucleoside analogue received accelerated approval from the US FDA at the end of 2004 for the treatment of paediatric patients 1–21 years old with relapsed or refractory acute lymphoblastic leukaemia after at least two prior regimens.
Multiple issued patents on this compound are jointly owned by Southern Research, SRI International and Memorial Sloan Kettering and licensed to Allos Therapeutics.
[16] MLP was founded by the NIH to fund research aimed at identifying new chemical probes against biological targets that might be amenable for drug therapy.
The division has also historically partnered with private sector firms and government agencies to develop new technologies that transform energy generation, chemical synthesis, and air and water purification.